Search Results (99)

Biopolymer-based films have attracted increasing attention as sustainable and bioactive materials for wound management. Among them, chitosan (CTS) and starch (ST) blend represent promising candidate due to their natural origin, biodegradability, and intrinsic biological activity; however, their mechanical weakness and limited stability necessitate additional modification. This study reports the development and characterization of CTS-ST thin films crosslinked with dialdehyde alginate (ADA), synthesized via controlled oxidation. Two ADA variants differing in aldehyde group content were prepared to investigate the effect of crosslinking on the structural, physicochemical, and biological performance of the materials. The films were fabricated by blending 2% w/v CTS and ST in varying mass ratios (75/25, 50/50, and 25/75), followed by the addition of ADA (5% w/w) and glycerol (5% w/w) as a plasticizer. The mixtures were then cast onto plates and dried under ambient conditions. Comprehensive characterization included Fourier-transform infrared spectroscopy, moisture content analysis, contact angle measurements, antioxidant activity assay, hemolysis testing, and cytotoxicity evaluation using human keratinocyte cells. The results demonstrated that both the ADA variant and CTS/ST ratio significantly influenced crosslinking efficiency, hydrophilicity, and antioxidant behavior. All samples exhibited non-hemolytic behavior and no significant cytotoxic effects, indicating their favorable biocompatibility. The combination of biostability, antioxidant ability, and absence of cytotoxic effects highlights the potential of ADA-crosslinking CTS/ST films for further development as wound dressing materials and other biomedical applications. Full article

In this work, kaolin/chitin (K/Ch) composite aerogels with different mass ratios were successfully fabricated via a freeze–drying approach. The influence of kaolin content on the microstructure, properties and hemostatic performance of the composite aerogels was systematically investigated. The results demonstrated that the incorporation of kaolin endowed the chitin-based aerogels with tunable porous structures, excellent water absorption capacity (up to 4282% for K_0.25/Ch₂), and enhanced water retention (73.7% for K₂/Ch₂ at 60 min). Moreover, the K/Ch composite aerogels exhibited good biodegradability, no cytotoxicity (cell viability > 91.9%), and no hemolysis (hemolysis rate < 1.5% at all test concentrations). In vitro hemostatic evaluations revealed that the composite aerogels exhibited rapid blood coagulation (blood clotting time of 16 s for K₂/Ch₂) with a blood coagulation index (BCI) as low as 0.5%, which was attributed to the synergistic effect of the physical adsorption of chitin and the coagulation cascade activation by kaolin. These findings indicated that the K/Ch composite aerogels could be used as novel natural hemostatic materials for potential effective and rapid hemostasis. Full article

A facile and single-step synthesis of poly(L-Cysteine) (p(L-Cys)) particles through microemulsion polymerization using tetrakis(hydroxymethyl) phosphonium chloride (THPC) as crosslinker is accomplished for the first time. The L-Cys:THPC ratio in p(L-Cys) particles was calculated as 80:20% (by weight) with elemental analyses, and the generation of p(L-Cys) particles was confirmed. SEM imaging revealed a popcorn-like morphology of the p(L-Cys) particles with a 1–20 µm particle size range. The isoelectric point of p(L-Cys) particles was determined at pH 1.15 via zeta potential measurements. The hydrolytic degradation of p(L-Cys) particles was determined as about 85% within 3 h (by weight). The p(L-Cys) particles displayed excellent blood compatibility with a hemolysis % ratio of <2.3% and a blood clotting index of 95% at 1 mg/mL concentration. Moreover, cell compatibility tests up to 50 mg/mL against L929 fibroblast cells exhibited about 90% cell viability for p(L-Cys) particles versus 58% for L-Cys molecule. The antimicrobial efficacy of the L-Cys molecules was notably enhanced in p(L-Cys) particles, exhibiting a 5-fold reduction in minimal bactericidal concentration (MBC) values against E. coli (Gram-negative, ATCC 8739) and a 2-fold reduction against S. aureus (Gram-positive, ATCC 6538). Additionally, the antioxidant capacity of p(L-Cys) particles was retained somewhat, measured as 0.14 ± 0.01 µM versus 2.25 ± 0.03 µM Trolox equivalent/g for L-Cys. Therefore, p(L-Cys) particles are versatile and offer a unique avenue for immense biomedical use. Full article

Lacticaseibacillus rhamnosus WH.FH-19 exhibits robust probiotic and technological traits for fermented dairy applications. L. rhamnosus WH.FH-19 shows superior functional potential compared to the benchmark strain Lacticaseibacillus rhamnosus GG. Kinetic studies confirm L. rhamnosus WH.FH-19’s vigorous growth and rapid acidification kinetics in bovine milk. In vitro characterization reveals enhanced probiotic properties, including significantly greater epithelial adhesion, tolerance to gastrointestinal stresses, cholesterol assimilation capacity, and antioxidant activity. Comprehensive safety assessment demonstrated the absence of hemolysis, sensitivity to clinically relevant antibiotics, and negligible tyramine production. Optimal synergistic fermentation with L. bulgaricus CICC 6047 and S. thermophilus CICC 6038 was achieved using a defined inoculum ratio. Under these conditions, L. rhamnosus WH.FH-19 specifically potentiated the activity of the S. thermophilus strain, accelerating fermentation kinetics without subsequent post-acidification while improving product sensory attributes. These findings establish L. rhamnosus WH.FH-19 as a safe, functionally robust probiotic with significant technological benefit for commercial fermented dairy production. Full article

Background/Objectives: According to the WHO, more than one million deaths of liver cancer patients will occur in 2030. Hepatocellular carcinoma (HCC) is the third leading cause of death among all cancer types. Doxorubicin is commonly used for the treatment of HCC, yet it possesses major side effects. The aim of this work was to formulate a nanoemulsion of Peltophorum pterocarpum extract containing bergenin intended for intravenous injection as a natural alternative to doxorubicin. Methods: The saturation solubility of the extract in different oils, surfactants, and co-surfactants was determined. Surfactant to co-surfactant mixtures (Smix) were used at six different weight ratios. A pseudoternary phase diagram was constructed, and the ratio with the highest area was chosen. Six formulations were prepared by changing the oil-to-Smix ratio. They were evaluated by percentage transmission, dilution test, self-emulsification, pH, viscosity, drug content, droplet size, PDI, zeta potential, TEM, in vitro drug release, stability, in vitro hemolysis percentage, and cytotoxicity (for the optimized formula). Results: F6 of oil-to-Smix ratio (1:6) was chosen for further investigations, as it possesses the lowest droplet size, the highest zeta potential, drug content, and in vitro drug release. The pH, viscosity, and self-emulsification time of F6 were also acceptable. F6 possesses shelf-life stability and is hemocompatible. It possesses high cytotoxicity against the HepG-2 cell line (IC₅₀ = 14.19 µg/mL). Conclusions: Although the nanoemulsion is less potent than doxorubicin in terms of IC₅₀, it offers a safer profile and natural origin, which may be used for the treatment of HCC. Full article

This study describes the development of β-cyclodextrin (β-CD) inclusion complexes of curcumin (CUR) and a synthetic curcuminoid analogue (CN56), which were incorporated into poly(vinyl alcohol)/κ-carrageenan hydrogel films to create a multifunctional system capable of sustained drug release and effective antimicrobial action. Carrageenan was extracted from Gigartina skottsbergii, and hydrogels were prepared using a freeze–thaw crosslinking method. The inclusion complexes were formed at a 1:6 molar ratio, achieving loading efficiencies of 75.62% for CUR and 79.00% for CN56. FTIR confirmed molecular interactions between the complexes and the polymeric matrix, accompanied by reduced crystallinity and increased amorphous character. Thermogravimetric analysis revealed enhanced thermal stability, with degradation onset temperatures above 239 °C, while DSC analysis indicated irreversible amorphization after the first heating cycle. SEM analysis showed improved surface uniformity in complex-loaded films compared with those containing free compounds. Swelling experiments demonstrated significantly greater fluid uptake in complex-loaded hydrogels, particularly for CN56 (1080% after 45 min). Controlled release studies revealed sustained drug release profiles, with 76.49% of CUR and 56.02% of CN56 released over 36 h, following Fickian diffusion mechanisms. In vitro antimicrobial assays confirmed marked activity of CUR and CN56 against Gardnerella vaginalis, a key pathogen associated with bacterial vaginosis. Biocompatibility tests, including hemolysis and MTT reduction assays, indicated low cytotoxicity and satisfactory hemocompatibility. Rheological analysis further demonstrated increased viscosity and potential mucoadhesive behavior. Collectively, these findings highlight the potential of carrageenan-based PVA hydrogels as innovative pharmaceutical platforms for the prevention and treatment of recurrent bacterial vaginosis, offering a promising alternative to conventional therapies. Full article

Hydrogels have attracted considerable attention as biomedical materials owing to their distinctive properties; however, improvements in mechanical strength, biodegradability, and biocompatibility remain essential for advanced clinical applications. This study developed a new dual-crosslinked hydrogel based on gelatin (Gel) and dextran (Dex) via sequential aldimine condensation and photopolymerization. Natural Gel and Dex were functionalized to synthesize methacrylated Gel (GelMA) and oxidized Dex (ODex), respectively. An imine-linked network was initially formed between GelMA and ODex via aldimine condensation, followed by a second crosslinked network generated through blue-light-induced free-radical polymerization of GelMA, yielding dual-crosslinked hydrogels (GMODs). ¹H NMR and FT–IR analyses confirmed the successful functionalization and formation of dual-crosslinked structure. The dual-crosslinked network enhanced the thermal stability and water-retaining capacity of the freeze-dried hydrogels (DGMODs) while reducing the surface wettability and equilibrium swelling ratio of GMODs. The maximum compressive strength (σₘ) increased with crosslinking density; GMOD−2, with moderate crosslinking density, remained intact under 85% compressive strain and achieved σₘ of 108.0 kPa. The degradation rate of GMODs was tunable by adjusting the crosslinking density, thereby modulating their drug-release behavior. GMOD−3, possessing the highest crosslinking density, exhibited effective drug-sustained release for up to five weeks. Biological evaluations, including cytotoxicity assays, live/dead cell staining, and hemolysis tests, verified excellent cytocompatibility (cell survival rate > 92%) and minimal hemolysis ratio (<5%). Furthermore, inhibition zone tests preliminarily revealed moderate antibacterial activity for GMOD−1. The GMOD hydrogels exhibited superior compressive robustness, adjustable biodegradability, and excellent biocompatibility, holding great potential for biomedical applications such as sustained drug-delivery system. Full article

Hemodialysis (HD) technology, pivotal in managing end-stage kidney disease, has witnessed significant advancements. Yet, the high cost of novel equipment often restricts its usage in resource-limited settings. This study introduces a two-filter adaptation to conventional HD machines, aimed at enhancing toxin removal while maintaining cost-effectiveness. Using a benchtop experimental setup, the performance of the adapted system was compared with that of standard HD. The results demonstrated that the two-filter system improved urea clearance rates by 54% compared with standard HD, without increasing albumin loss or causing additional hemolysis. In a pilot study of four HD patients, the modified setup achieved a higher single-pool Kt/V (1.82) and urea-reduction ratio (80%). These findings underscore the potential of this adaptation to enhance HD machine efficiency without additional patient risks, thereby offering a feasible solution for improving access to advanced renal therapies in under-resourced areas. Further clinical trials with larger populations are warranted to validate these benefits and evaluate middle-molecule clearance for comparison with hemodiafiltration (HDF). Full article

The present study aims to optimize the extraction process and systematically investigate the bioactivity of polysaccharides derived from Peristrophe roxburghiana (Schult.) Brem. (CPPRs). To this end, the Box–Behnken design–response surface methodology was employed to optimize the extraction parameters of polysaccharides. The optimal extraction conditions were as follows: extraction temperature, 84 °C; extraction duration, 208 min; liquid-to-material ratio, 1:27 g/mL; extraction times, 4 times. The maximum extraction yield reached 17.89%, and the yield under non-optimal extraction conditions is 11–16%. This study systematically investigated the polysaccharides’ physicochemical, structural, and morphological properties using multiple advanced techniques (FTIR, SEM, XRD, HPLC, rheology, and TGA). CPPRs are primarily composed of arabinose, galactose and glucose as the main monosaccharides, amorphous, and capable of low-viscosity gels at low shear rates. Furthermore, CPPRs displayed notable antioxidant activity in vitro, scavenging ABTS^•+ and DPPH^• and reducing Fe³⁺ (with scavenging/reducing rates exceeding 40% at a concentration of 1 mg/mL). Meanwhile, 3 mg/mL CPPRs reduced oxidative damage of red blood cells induced by AAPH, scavenging more than 50% of ROS, and reducing the hemolysis rate by 94.5%. Additionally, CPPRs significantly promoted secretion of cytokines (including TNF-α, IL-6, and IL-10) and NO in RAW264.7 macrophages in vitro compared with the untreated control group. These findings collectively highlight the potential of CPPRs—possessing both antioxidant and immune-enhancing properties—as promising functional ingredients for application in the food and pharmaceutical industries. Full article

We investigated the influence of gold deposition on the magnetic behavior, biocompatibility, and bioactivity of CoFe₂O₄ (MCF) nanomaterials (NMs) functionalized with sodium citrate (Cit) or glycine (Gly). The resulting multifunctional plasmonic nanostructured materials (MCF-Au-L, where L is Cit, Gly) exhibit superparamagnetic behavior with magnetic saturation of 59 emu/g, 55 emu/g, and 60 emu/g, and blocking temperatures of 259 K, 311 K, and 322 K for pristine MCF, MCF-Au-Gly, and MCF-Au-Cit, respectively. The MCF NMs exhibit a small uniform size (with a mean size of 7.1 nm) and an atomic ratio of Fe:Co (2:1). The gold nanoparticles (AuNPs) show high heterogeneity as determined by high-resolution transmission electron microscopy (HR-TEM) and energy-dispersive X-ray spectroscopy (EDX). The UV-Vis spectroscopy of the composites reveals two localized surface plasmons (LSPs) at 530 nm and 705 nm, while Fourier Transformed-Infrared spectroscopy (FTIR) and thermogravimetric analysis (TGA) confirm the presence of Cit and Gly on their surface. Subsequent biocompatibility tests confirm that MCF-Au-L NMs do not exert hemolytic activity (hemolysis < 5%). In addition, the CCK-8 viability assay tests indicate the higher sensitivity of cancerous cells (A549) to the photoactivity of MCF-Au compared to healthy Detroit 548 (D548) cell lines. We use advanced microscopy techniques, namely atomic force, fluorescence, and holotomography microscopies (AFM, FM, and HTM, respectively) to provide further insights into the nature of the observed photoactivity of MCF-Au-L NMs. In addition, in situ radiation, using a modified HTM microscope with an IR laser accessory, demonstrates the photoactivity of the MCF-Au NMs and their suitability for destroying cancerous cells through photodynamic therapy. The combined imaging capabilities demonstrate clear morphological changes, NMs internalization, and oxidative damage. Our results confirm that the fabricated multifunctional NMs exhibit high stability in aqueous solution, chemical solidity, superparamagnetic behavior, and effective IR responses, making them promising precursors for hybrid cancer therapy. Full article

This study involved the fabrication of poly (vinyl alcohol) (PVA) nanocomposite films using the solution-casting process, which incorporated strontium-coated silver oxide (Sr-Ag₂O) nanoparticles generated by a plant-extract assisted method. Various characterization techniques, such as XRD, SEM, TEM, UV, and FTIR, showed the formation and uniform distribution of Sr-Ag₂O nanoparticles in the PVA film, which are biocompatible nanocomposite films. The presence of hydroxyl groups leads to appreciable mixing and interaction between the Sr-Ag₂O nanoparticles and the PVA polymer. Mechanical and thermal results suggest enhanced tensile strength and increased thermal stability. In addition, the sample of PVA/Sr-Ag₂O (1.94/0.06 wt. ratio) nanocomposite film showed decreased hydrophilicity, lower hemolysis, non-toxicity, and appreciable cell migration activity, with nearly 19.95% cell migration compared to the standard drug, and the presence of Sr-Ag₂O nanoparticles favored the adhesion and spreading of cells, which triggered the reduction in the gaps. These research findings suggest that PVA/Sr-Ag₂O nanocomposite films with good mechanical, antimicrobial, non-toxic, and biocompatible properties could be applied in biological wound-healing applications. Full article

Equine piroplasmosis (EP), caused by Theileria equi and Babesia caballi, is a worldwide tick-borne disease with severe economic, commercial, and sanitary implications for equids. Although diagnosis is based on direct (blood smear or PCR) or indirect (serology) methods, these techniques are expensive, laborious, and false-negative and false-positive results can be yielded. Biochemistry blood profiles are routinely performed in horses. Biochemical parameters and ratios could be a reliable complementary diagnostic tool to assist clinicians in EP diagnosis, mainly in endemic areas, or for discarding similar disorders (piro-like diseases) and prioritizing specific diagnostic testing. This study describes the changes induced by EP infection in blood biochemical parameters and common and novel biochemical ratios in horses. EP-infected horses showed increased serum total and indirect bilirubin, triglycerides, and GLDH concentrations and decreased sodium concentrations compared to non-infected animals. These findings could be linked to hemolysis, diminution of athletic performance, and liver inflammation due to oxidative stress damage. While molecular methods remain the gold standard for EP diagnosis, a complete biochemical profile and ratios could provide valuable complementary information to enhance the diagnostic accuracy of piroplasmosis in horses. Full article

Background: Hemolysis during sepsis may be driven by patient-specific factors, including the intensity of the inflammatory response and the etiology of infection, as well as treatment-related factors, such as the use of extracorporeal life-support devices. Methods: We evaluated the incidence of hemolysis—reflected by decreased plasma levels of haptoglobin and hemopexin—in a cohort of septic patients with acute respiratory failure (n = 50) admitted to the intensive care unit (ICU). Results: Hemolysis was observed in 60% of patients. Its incidence was significantly higher among those with septic shock (86%) and those receiving extracorporeal membrane oxygenation (ECMO) therapy (81%). While continuous renal replacement therapy (CRRT) alone did not increase the incidence of hemolysis, its combination with ECMO was associated with hemolysis in 100% of those treated. Logistic regression analysis identified low haptoglobin levels (odds ratio [OR] 27.1), advanced age (OR 1.2), and stage 3 acute kidney injury (OR 22.2) as significant predictors of mortality. Conclusions: These findings highlight the clinical relevance of monitoring hemolysis in septic patients. Given the routine availability of haptoglobin and hemopexin assays in most hospital laboratories, these biomarkers offer practical and accessible tools for the detection and monitoring of hemolysis in critically ill patients. Full article

Acute erythroid leukemia (AEL) is a rare and aggressive hematological malignancy managed with chemotherapy, targeted therapies, and stem cell transplantation. However, these treatments often suffer from limitations such as refractoriness, high toxicity, recurrence, and drug resistance, underscoring the urgent need for novel therapeutic approaches. Dibromo-edaravone (D-EDA) is a synthetic derivative of edaravone (EDA) with unreported anti-leukemic properties. In this study, D-EDA demonstrated potent cytotoxicity against HEL cells with an IC₅₀ value of 8.17 ± 0.43 μM using an MTT assay. Morphological analysis via inverted microscopy revealed reductions in cell number and signs of cellular crumpling and fragmentation. Flow cytometry analysis, Hoechst 33258 staining, Giemsa staining, a JC-1 assay, and a reactive oxygen species (ROS) assay showed that D-EDA induced apoptosis in HEL cells. Furthermore, D-EDA induced S-phase cell cycle arrest. Western blot analysis showed significant upregulation of key apoptosis-related proteins, including cleaved caspase-9, cleaved caspase-3, and cleaved poly ADP-ribose polymerase (PARP), alongside a reduction in Bcl-2 expression. Additionally, oncogenic markers such as c-Myc, CyclinA2, and CDK2 were downregulated, while the cell cycle inhibitor p21 was upregulated. Mechanistic studies involving molecular docking, a cellular thermal shift assay (CETSA), the caspase inhibitor Z-VAD-FMK, JAK2 inhibitor Ruxolitinib, and STAT3 inhibitor Stattic revealed that D-EDA activates the caspase cascade and inhibits the JAK2-STAT3 signaling pathway in HEL cells. In vivo, D-EDA improved spleen structure, increased the hemolysis ratio, and extended survival in a mouse model of acute erythroleukemia. In conclusion, D-EDA induces apoptosis via the caspase cascade and JAK2-STAT3 signaling pathway, demonstrating significant anti-leukemia effects in vitro and in vivo. Thus, D-EDA may be developed as a potential therapeutic agent for acute erythroleukemia. Full article

Wound infections remain a significant clinical challenge, impeding healing and causing deterioration. Recently, multifunctional hydrogel dressings have gained interest as an effective treatment to treat infections efficiently and enhance wound recovery. The present research is focused on the development of composite hydrogels comprising chitosan (CS), polyvinyl alcohol (PVA), gelatin (GEL) and licorice extract (LE), using the freeze gelation technique. The resulting composite hydrogels of CS/PVA/GEL incorporating LE were characterized by FTIR, XRD and SEM. FTIR analysis confirmed the presence of specific functional groups within the molecules. XRD exhibited the amorphous nature of hydrogels. SEM analysis revealed that increasing the CS ratio in hydrogels created a more porous structure with a smaller pore size. All the hydrogels demonstrated oxygen permeability, which is crucial for the healing process. Among the synthesized hydrogels, MM-2 containing PVA (20 mL) and LE (4 mL) demonstrated superior performance with a water retention capacity of 440% and moisture content of 91%. This exceptional result can be attributed to the higher proportion of PVA and the material’s porous structure, which enhances its hydrophilic properties. The synthesized hydrogels showed good antibacterial potential against three selected strains of bacteria including Bacillus subtilis (B. subtilis), Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli). The hydrogels’ cytotoxicity levels were assessed through hemolysis assay and the results demonstrated that all hydrogels were non-toxic. The hydrolytic breakdown revealed that the interconnected hydrogels with licorice components exhibited slow degradation, making them more appropriate for long-term wound treatment. Specifically, MM-4 demonstrated a 74% degradation rate and displayed 75% antioxidant activity, indicating its potential effectiveness for chronic wound applications. These characteristics of synthesized CS/PVA/GEL/LE-derived hydrogels suggest their potential use as a promising candidate for wound care applications. Full article